Histoculture drug response assay predicts chemotherapy efficacy and improves survival in gastrointestinal cancers
In summary, the HDRA assay represents a reliable assay for accurately evaluating chemotherapy regimens, thereby furnishing guidance for individualized treatment in gastrointestinal cancer patients.
Authors
- Chenggang Yang
- Shuang Wang (ORCID: https://orcid.org/0000-0002-9189-602X)
- Yang Li (ORCID: https://orcid.org/0000-0002-4277-9214)
- Dongliang Chen (ORCID: https://orcid.org/0000-0002-8223-2803)
- Li Han (ORCID: https://orcid.org/0000-0002-4486-0534)
- Ping Hu (ORCID: https://orcid.org/0009-0008-1506-7319)
- Xiaohong Jiang
- Lei Gao (ORCID: https://orcid.org/0000-0002-3897-6362)
- Dawei Yang
- Na Fan (ORCID: https://orcid.org/0009-0000-9635-0360)
Institutions
- Liaocheng People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fonc.2025.1596253
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00